Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Precision Medicine Strategies to Improve Isoniazid Therapy in Patients with Tuberculosis ; volume:49 ; number:5 ; day:17 ; month:8 ; year:2024 ; pages:541-557 ; date:9.2024
European journal of drug metabolism and pharmacokinetics ; 49, Heft 5 (17.8.2024), 541-557, 9.2024
- Urheber
-
Thomas, Levin
Raju, Arun Prasath
Mallayasamy, Surulivelrajan
Rao, Mahadev
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13318-024-00910-7
- URN
-
urn:nbn:de:101:1-2411162138239.809614282955
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thomas, Levin
- Raju, Arun Prasath
- Mallayasamy, Surulivelrajan
- Rao, Mahadev
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment of isoniazid-resistant pulmonary tuberculosis
Steps to Improve Precision Medicine in Epilepsy
A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
Correction to: A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
Precision Medicine
Engineering Precision Medicine
Precision regenerative medicine
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
Personalisierte Tumormedizin : precision medicine
EFLM Symposium - Precision Medicine
Treatment of isoniazid-resistant pulmonary tuberculosis
Steps to Improve Precision Medicine in Epilepsy
A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
Correction to: A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
Precision Medicine
Engineering Precision Medicine
Precision regenerative medicine
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
Personalisierte Tumormedizin : precision medicine
EFLM Symposium - Precision Medicine
Treatment of isoniazid-resistant pulmonary tuberculosis
Steps to Improve Precision Medicine in Epilepsy
A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
Towards a new tuberculosis drug: pyridomycin – nature's isoniazid
Correction to: A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
Precision Medicine
Engineering Precision Medicine
Precision regenerative medicine
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis
Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review
Personalisierte Tumormedizin : precision medicine